Literature DB >> 11794633

Bioavailability of US commercial magnesium preparations.

M Firoz1, M Graber.   

Abstract

Magnesium deficiency is seen with some frequency in the outpatient setting and requires oral repletion or maintenance therapy. The purpose of this study was to measure the bioavailability of four commercially-available preparations of magnesium, and to test the claim that organic salts are more easily absorbed. Bioavailability was measured as the increment of urinary maginesium excretion in normal volunteers given approximately 21 mEq/day of the test preparations. Results indicated relatively poor bioavailability of magnesium oxide (fractional absorption 4 per cent) but significantly higher and equivalent bioavailability of magnesium chloride, magnesium lactate and magnesium aspartate. We conclude that there is relatively poor bioavailability of magnesium oxide, but greater and equivalent bioavailability of magnesium chloride, lactate, and aspartate. Inorganic magnesium salts, depending on the preparation, may have bioavailability equivalent to organic magnesium salts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11794633

Source DB:  PubMed          Journal:  Magnes Res        ISSN: 0953-1424            Impact factor:   1.115


  21 in total

Review 1.  Hypomagnesaemia and pregnancy.

Authors:  Adam Morton
Journal:  Obstet Med       Date:  2018-03-07

2.  Epidermal growth factor receptor inhibitor-induced hypomagnesemia: a survey of practice patterns among Canadian gastrointestinal medical oncologists.

Authors:  T Thangarasa; J Gotfrit; R A Goodwin; P A Tang; M Clemons; A Imbulgoda; M M Vickers
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

3.  Bioavailability of magnesium from different pharmaceutical formulations.

Authors:  Roswitha Siener; Andrea Jahnen; Albrecht Hesse
Journal:  Urol Res       Date:  2010-09-23

4.  A New Caco-2 Cell Model of in Vitro Intestinal Barrier: Application for the Evaluation of Magnesium Salts Absorption.

Authors:  J Kyselovič; N Chomanicová; A Adamičková; S Valášková; B Šalingová; A Gažová
Journal:  Physiol Res       Date:  2021-11-30       Impact factor: 1.881

5.  Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis.

Authors:  N N Sanders; H Franckx; K De Boeck; J Haustraete; S C De Smedt; J Demeester
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

6.  Features of central neurotransmission in animals in conditions of dietary magnesium deficiency and after its correction.

Authors:  A A Spasov; I N Iezhitsa; M S Kravchenko; M V Kharitonova
Journal:  Neurosci Behav Physiol       Date:  2009-07-21

7.  Do the Micronutrients Zinc and Magnesium Play a Role in Adult Depression?

Authors:  Barbra Dickerman; Jianghong Liu
Journal:  Top Clin Nutr       Date:  2011 Jul-Sep       Impact factor: 0.508

8.  Synthesis and Chemical and Biological Evaluation of a Glycine Tripeptide Chelate of Magnesium.

Authors:  Derek R Case; Jon Zubieta; Ren Gonzalez; Robert P Doyle
Journal:  Molecules       Date:  2021-04-21       Impact factor: 4.411

9.  Hypomagnesemia and hypokalemia: a successful oral therapeutic approach after 16 years of potassium and magnesium intravenous replacement therapy.

Authors:  Mihran Naljayan; Suresh Kumar; Theodore Steinman; Efrain Reisin
Journal:  Clin Kidney J       Date:  2014-03-05

10.  Magnesium replacement does not improve insulin resistance in patients with metabolic syndrome: a 12-week randomized double-blind study.

Authors:  Maria de Lourdes Lima de Souza E Silva; Thomaz Cruz; Luiz Erlon Rodrigues; Ana Marice Ladeia; Olivia Bomfim; Lucas Olivieri; Juliana Melo; Raquel Correia; Mirna Porto; Alexandre Cedro
Journal:  J Clin Med Res       Date:  2014-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.